Literature DB >> 22262105

Current progress in xenogeneic tolerance.

Kazuhiko Yamada1, Joseph Scalea.   

Abstract

PURPOSE OF REVIEW: The present review updates the current status of research regarding the immunologic responses of the recipient following xenotransplantation. Additionally, we present the recent progress with attempts to induce xenogeneic tolerance induction. RECENT
FINDINGS: There continues to be great interest in xenotransplantation. Recently, descriptions of the mechanisms responsible for attempted T-cell xenogeneic tolerance in both large and small animal models have improved xenogeneic graft survivals. Additionally, the cellular signaling mechanisms, such as those involving CD39, CD44, and CD47, are proving to be highly important. Using the mixed chimerism approach to tolerance in xenogeneic model may be encouraging, especially given the recent clarification of the role for macrophage-induced phagocytosis of xenogeneic donor cells.
SUMMARY: Induction of tolerance to xenogeneic antigens has been accomplished only in small animals; however, graft survivals in large animal models continue to improve. Further clarification of both the adaptive and innate immune responses to xenogeneic antigens is required for success to continue.

Entities:  

Mesh:

Year:  2012        PMID: 22262105      PMCID: PMC3600376          DOI: 10.1097/MOT.0b013e32835090f6

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  65 in total

1.  Donation after cardiac death liver transplantation: predictors of outcome.

Authors:  A K Mathur; J Heimbach; D E Steffick; C J Sonnenday; N P Goodrich; R M Merion
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

2.  Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons.

Authors:  Adam Griesemer; Fan Liang; Atsushi Hirakata; Erica Hirsh; Diana Lo; Masayoshi Okumi; Megan Sykes; Kazuhiko Yamada; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

Review 3.  CD47: a new player in phagocytosis and xenograft rejection.

Authors:  Nalu Navarro-Alvarez; Yong-Guang Yang
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

4.  Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases.

Authors:  Janet Hauschild; Bjoern Petersen; Yolanda Santiago; Anna-Lisa Queisser; Joseph W Carnwath; Andrea Lucas-Hahn; Lei Zhang; Xiangdong Meng; Philip D Gregory; Reinhard Schwinzer; Gregory J Cost; Heiner Niemann
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

5.  Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells.

Authors:  Michael D Green; Antonia Chen; Maria-Cristina Nostro; Sunita L d'Souza; Christoph Schaniel; Ihor R Lemischka; Valerie Gouon-Evans; Gordon Keller; Hans-Willem Snoeck
Journal:  Nat Biotechnol       Date:  2011-02-27       Impact factor: 54.908

6.  First experience with the use of a recombinant CD3 immunotoxin as induction therapy in pig-to-primate xenotransplantation: the effect of T-cell depletion on outcome.

Authors:  Hiroaki Nishimura; Joseph Scalea; Zhirui Wang; Akira Shimizu; Shannon Moran; Bradford Gillon; David H Sachs; Kazuhiko Yamada
Journal:  Transplantation       Date:  2011-09-27       Impact factor: 4.939

7.  Xenoreactive CD4+ memory T cells resist inhibition by anti-CD44 mAb and reject islet grafts via a Th2-dependent pathway.

Authors:  Yuanzheng Peng; Jibing Chen; Wei Shao; Feiyu Wang; Helong Dai; Panpan Cheng; Junjie Xia; Feng Wang; Ruxin Huang; Qi Zhu; Zhongquan Qi
Journal:  Xenotransplantation       Date:  2011 Jul-Aug       Impact factor: 3.907

8.  Prolonged xenograft survival induced by inducible costimulator-Ig is associated with increased forkhead box P3(+) cells.

Authors:  Russell Hodgson; Dale Christiansen; Andrew Ziolkowski; Effie Mouhtouris; Charmaine J Simeonovic; Francesco L Ierino; Mauro S Sandrin
Journal:  Transplantation       Date:  2011-05-27       Impact factor: 4.939

9.  Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma(c)-/- mice improves engraftment of human hematopoietic cells in humanized mice.

Authors:  Till Strowig; Anthony Rongvaux; Chozhavendan Rathinam; Hitoshi Takizawa; Chiara Borsotti; William Philbrick; Elizabeth E Eynon; Markus G Manz; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

10.  CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.

Authors:  P Thompson; K Cardona; M Russell; I R Badell; V Shaffer; G Korbutt; G R Rayat; J Cano; M Song; W Jiang; E Strobert; R Rajotte; T Pearson; A D Kirk; C P Larsen
Journal:  Am J Transplant       Date:  2011-05       Impact factor: 8.086

View more
  4 in total

1.  Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation.

Authors:  A Tena; J Kurtz; D A Leonard; J R Dobrinsky; S L Terlouw; N Mtango; J Verstegen; S Germana; C Mallard; J S Arn; D H Sachs; R J Hawley
Journal:  Am J Transplant       Date:  2014-10-02       Impact factor: 8.086

Review 2.  The immune system in infants: Relevance to xenotransplantation.

Authors:  Mohamed Bikhet; Mahmoud Morsi; Hidetaka Hara; Leslie A Rhodes; Waldemar F Carlo; David Cleveland; David K C Cooper; Hayato Iwase
Journal:  Pediatr Transplant       Date:  2020-08-26

3.  Xenotransplantation of human cultured parathyroid progenitor cells into mouse peritoneum does not induce rejection reaction.

Authors:  Ireneusz Nawrot; Bogdan Woźniewicz; Jacek Szmidt; Dariusz Śladowski; Krzysztof Zając; Witold Chudziński
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

4.  The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System.

Authors:  Carlos Galeano; Zhifang Qiu; Anuja Mishra; Steven L Farnsworth; Jacob J Hemmi; Alvaro Moreira; Peter Edenhoffer; Peter J Hornsby
Journal:  Cell Transplant       Date:  2018-05-14       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.